Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform | #endurecar-T™ Cell Therapy Platform

Science et technologie

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform

Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.

Cost-effective Animal Disease Models to Power Up Life Science Research | #animal disease models

Science et technologie

Cost-effective Animal Disease Models to Power Up Life Science Research

A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released.

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease | #systemic Mitochondrial Disease

Science et technologie

Protheragen Launches Specialized Services to Support Research on Systemic Mitochondrial Disease

Protheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease.

Protheragen Advances Gene Therapy Research with Comprehensive Adeno-Associated Virus (AAV) Vector Platform | #adeno-Associated Virus (AAV) Vector Platform

Science et technologie

Protheragen Advances Gene Therapy Research with Comprehensive Adeno-Associated Virus (AAV) Vector Platform

Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development.